Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1

作者: Patrick Combemale , Laurence Valeyrie-Allanore , Francesco Giammarile , Stephane Pinson , Bernard Guillot

DOI: 10.1371/JOURNAL.PONE.0085954

关键词:

摘要: Background Malignant peripheral nerve sheath tumors (MPNSTs) are a serious complications of neurofibromatosis type 1 associated with poor prognosis and deeper lesions can be difficult to diagnose. 18-FDG PET improves the detection malignancies. However, criteria for malignancy, notably SUVmax threshold, not standardized. Therefore, aim study was evaluate semi-quantitative index reproducible MPNST FDG PET. Methods It is multicenter retrospective conducted between 2000 2012. All patients NF1 referred suspected underwent PET. Since available until 2004 in our centers, we had settle method used at that time, uptake ratio tumor normal liver (T/L ratio) 1.5 as cut-off malignancy. When dedicated became available, analysis images remained, along SUVmax. Results 113 145 were included. assessment revealed 65 T/L >1.5 among these, 40 MPNSTs. 80 classified non-suspicious, 79 benign. The negative predictive value (NPV) 98,8% positive 61,5%. likelihood (LR) 4,059, LR 0,032 97% sensitivity 76% specificity. Conclusions This study, which largest published, confirms utility detecting NF1-associated A index, 1.5, allowed sensitive specific differentiation malignant from benign better than SUVmax. there strong suspicion This analytical simple SUVmax, but more sensitive, non-user-dependent.

参考文章(54)
Mark R. Wick, Paul E. Swanson, Bernd W. Scheithauer, J. Carlos Manivel, Malignant peripheral nerve sheath tumor. An immunohistochemical study of 62 cases. American Journal of Clinical Pathology. ,vol. 87, pp. 425- 433 ,(1987) , 10.1093/AJCP/87.4.425
Virendra Kumar, Kavindra Nath, Claudia G. Berman, Jongphil Kim, Tawee Tanvetyanon, Alberto A. Chiappori, Robert A. Gatenby, Robert J. Gillies, Edward A. Eikman, Variance of SUVs for FDG-PET/CT is Greater in Clinical Practice Than Under Ideal Study Settings Clinical Nuclear Medicine. ,vol. 38, pp. 175- 182 ,(2013) , 10.1097/RLU.0B013E318279FFDF
H. Schicha, P. Theissen, M. Schmidt, M. Schmalenbach, W. Eschner, M. Dietlein, M. Jungehülsing, U. Schröder, E. Stennert, 18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis. Nuklearmedizin-nuclear Medicine. ,vol. 43, pp. 91- 101 ,(2004) , 10.1267/NUKL04030091
E. F. Patz, V. J. Lowe, J. M. Hoffman, R. E. Coleman, D. M. DeLong, Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. The Journal of Nuclear Medicine. ,vol. 35, pp. 1771- 1776 ,(1994)
J R Crim, L L Seeger, L Yao, V Chandnani, J J Eckardt, Diagnosis of soft-tissue masses with MR imaging : can benign masses be differentiated from malignant ones ? Radiology. ,vol. 185, pp. 581- 586 ,(1992) , 10.1148/RADIOLOGY.185.2.1410377
S. Cardona, M. Schwarzbach, Ulf Hinz, A. Dimitrakopoulou-Strauss, N. Attigah, G. Mechtersheimer§, T. Lehnert, Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours Ejso. ,vol. 29, pp. 536- 541 ,(2003) , 10.1016/S0748-7983(03)00055-6
Hideki Otsuka, Michael M. Graham, Akiko Kubo, Hiromu Nishitani, FDG-PET/CT findings of sarcomatous transformation in neurofibromatosis: a case report Annals of Nuclear Medicine. ,vol. 19, pp. 55- 58 ,(2005) , 10.1007/BF02986337
J. Zeller, J. Wechsler, J. Revuz, P. Wolkenstein, L. Valeyrie-Allanore, N. Ismaili, S. Bastuji-Garin, Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1. British Journal of Dermatology. ,vol. 153, pp. 79- 82 ,(2005) , 10.1111/J.1365-2133.2005.06558.X
Allison A. King, Michael R. Debaun, Vincent M. Riccardi, David H. Gutmann, Malignant peripheral nerve sheath tumors in neurofibromatosis 1. American Journal of Medical Genetics. ,vol. 93, pp. 388- 392 ,(2000) , 10.1002/1096-8628(20000828)93:5<388::AID-AJMG8>3.0.CO;2-#